ANALYSIS: With an Obermatt 360° View of 28 (better than 28% compared with alternatives), overall professional sentiment and financial characteristics for the stock Panion & Bf Biotech are below the industry average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Panion & Bf Biotech. The consolidated Sentiment Rank has a good rank of 78, which means that professional investors are more optimistic about the stock than for 78% of alternative investment opportunities. But all other ranks are below average. The consolidated Value Rank has a rank of 26, which means that the share price of Panion & Bf Biotech is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. The consolidated Growth Rank also has a low rank of 32, meaning that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. This means that growth is lower than for 32% of competitors in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 20 which means that the company has a riskier financing structure than 80% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more